Appeal No. 2001-1489 Page 2
Application No. 09/177,695
Claims 1 and 11 are illustrative of the claims on appeal and read as follows:
1. A method for cosmetically improving human skin through a treatment regime
comprising:
providing a first composition containing at least one first active within a first
pharmaceutically acceptable carrier, the first composition functioning to impart a first
benefit to the skin;
providing a second composition containing at least one second active within a
second pharmaceutically acceptable carrier, the second composition functioning to
impart a second benefit to the skin, the first and second actives and benefits being
different from one another;
storing the first composition in a first container;
storing the second composition in a second container, the first and second
containers being joined together;
instructing consumers by placing on the containers or packaging associated
therewith instructions on use of the first and second compositions in a sequential
manner to achieve the first and second benefits in a treatment regime, the first and
second compositions being complementary products;
applying the first composition to the skin to achieve the first benefit; and
applying the second composition to the skin after application of the first
composition to achieve the second benefit.
11. A skin treatment regime product comprising:
a first composition containing at least one first active within a first
pharmaceutically acceptable carrier, the first composition functioning to impart a first
benefit to the skin;
a second composition containing at least one second active within a second
pharmaceutically acceptable carrier, the second composition functioning to impart a
second benefit to the skin;
a first container for storing the first composition;
a second container for storing the second composition, the first and second
containers being joined together; and
instructions for consumers placed on the containers or packaging associated
therewith on use of the first and second compositions in a sequential manner to achieve
the first and second benefits in a treatment regime, the first and second compositions
being complementary products.
The references relied upon by the examiner are:
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007